Polymorphism in drugs investigated by low wavenumber Raman scattering

Vibrational Spectroscopy

Volumn 45, Issue 2, 2007, Pages 112-116

  Ayala, Alejandro Pedro ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Ab initio calculations; Active ingredients pharmaceutical; Differential scanning calorimetry; Drugs; Polymorphism; Raman scattering

Indexed keywords

CRYSTALLINE MATERIALS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PRODUCTS; RAMAN SCATTERING; SENSITIVITY ANALYSIS; X RAY DIFFRACTION;

AB INITIO CALCULATIONS; ACTIVE INGREDIENTS PHARMACEUTICALS; DRUGS; MOLECULAR SKELETON DEFORMATIONS; WAVE NUMBERS; WAVENUMBER RAMAN ACTIVE VIBRATIONAL MODES;

POLYMORPHISM;

EID: 36549010525     PISSN: 09242031     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vibspec.2007.06.004     Document Type: Article

References (24)

1. Bugay D.E. Adv. Drug Deliv. Rev. 48 (2001) 43
2. Taday P.F. Phil. Trans. R. Soc. Lond. A 362 (2004) 351
3. Hudson B.S. J. Phys. Chem. A 105 (2001) 3949
4. Johnson M.R., Prager M., Grimm H., Neumann M.A., Kearley G.J., and Wilson C.C. Chem. Phys. 244 (1999) 49
5. Findlay W.P., and Bugay D.E. J. Pharm. Biomed. Anal. 16 (1998) 921
6. Fini G. J. Raman Spectrosc. 35 (2004) 335
7. Vankeirsbilck T., Vercauteren A., Baeyens W., Van der Weken G., Verpoort F., Vergote G., and Remon J.P. Trends Anal. Chem. 21 (2002) 869
8. Wartewig S., and Neubert R.H.H. Adv. Drug Deliv. Rev. 57 (2005) 1144
9. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery Jr. J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Gonzalez C., and Pople J.A. Gaussian 03, Revision C. 02 (2004), Gaussian, Inc., Wallingford CT
10. Ayala A.P., Siesler H.W., Wardell S.M.S.V., Boechat N., Dabbene V., and Cuffini S.L. J. Mol. Struct. 828 (2007) 201
11. Cuffini S.L., Ellena J.F., Mascarenhas Y.P., Ayala A.P., Sielser H.W., Filho J.M., Monti G.A., Aiassa V., and Sperandeo N.R. Steroids 72 (2007) 261
12. Shorvon S. Seizure 9 (2000) 75-79
13. Hempel A., Camerman N., Camerman A., and Mastropaolo D. Acta Cryst. E61 (2005) O1313
14. S. Faudone, J. Ellena, Y.P. Mascarenhas, C. Olmos, A. Karlsson, A.P. Ayala, N.R. Sperandeo, S.L. Cuffini, 2007, unpublished results.
15. Burger A. Sci. Phar. 43 (1975) 152
16. S. Faudone, S.L. Cuffini, A.P. Ayala, J. Ellena, 2007, unpublished results.
17. Drebushchak T.N., Chukanov N.V., and Boldyreva E.V. Acta Cryst. E62 (2006) O4393
18. Koo C.H. Arch. Pharmacol. Res. 3 (1980) 37
19. Fulton B., and Goa K.L. Drugs 53 (1997) 281
20. Reutzel-Edens S.M., Bush J.K., Magee P.A., Stephenson G.A., and Byrn S.R. Cryst. Growth Des. 3 (2003) 897
21. Capuano B., Crosby I.T., Fallon G.D., Lloyd E.J., Yuriev E., and Egan S.J. Acta Cryst. E59 (2003) O1367
22. Wawrzycka-Gorczyca I., Mazur L., and Koziol A.E. Acta Cryst. E60 (2004) O69
23. Polla G.I., Vega D.R., Lanza H., Tombari D.G., Baggio R., Ayala A.P., Filho J.M., Fernandez D., Leyva G., and Dartayet G. Int. J. Pharm. 301 (2005) 33-40
24. Ayala A.P., Siesler H.W., Boese R., Hoffmann G.G., Polla G.I., and Vega D.R. Int. J. Pharm. 326 (2006) 69